India has entered the second phase of immunization against novel coronavirus. Above 45-years-old are being administered homegrown vaccines against the virus Covaxin and Covishield.
A senior citizen in West Bengal’’s Dhupguri area died allegedly after being administered the Covishield vaccine, prompting his family members to lodge a police complaint, an official said on Tuesday.
Krishna Dutta (64), a businessman from the Jalpaiguri district, died at a local hospital, where he was rushed after he complained of breathlessness. According to the family members “Dutta was administered the vaccine on Monday.
He was having breathing issues at night, and taken to hospital, where he was declared dead after a while”. The family members of the deceased have registered a complaint with the police regarding the same.
Speaking to the media, the health officials said that the man who died following the Covishield vaccine shot for COVID-19 was suffering from several comorbidities. “Dutta’s body has been sent to Jalpaiguri State General Hospital for autopsy and an investigation has also been initiated to look into the matter,” the officials were quoted as saying.
Coming to the vaccine part, Covishield and Covaxin are the two vaccines that are being administered to the common people in the country. The government hospitals are not charging anything for the vaccines, however, if someone wants to get vaccinated in a private hospital the charges will remain at Rs 250 per shot.
There was no adverse event following immunisation (AEFI) reported from anywhere in West Bengal, the official said. Till Tuesday, 18.43 lakh people were vaccinated.
West Bengal registered one more COVID-19 death, pushing the toll to 10,281, a bulletin issued by the department said.
The coronavirus tally mounted to 5,77,026 with 188 fresh cases, it said. The state now has 3,144 active cases, while 5,63,601 people have recovered from the disease thus far.
